Kaplan-Meier survival plots comparing ICC defined patients. (A, B) OS and EFS between AML with mutated TP53, AML-MR defined by gene mutations (AML-MR-M), AML-MR defined by cytogenetics (AML-MR-CG), AML not otherwise specified (AML-NOS). (C, D) OS and EFS in patients with reversed defining order of AML-MR.